Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1807-1814

  Wang, Qing ^a   Zhang, Yan ^a   Yang, Hsin Sheng ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

AP 1; C Myc; JNK signaling pathway; MAP4K1; Pdcd4

Indexed keywords

BETA CATENIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; STRESS ACTIVATED PROTEIN KINASE; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BINDING SITE; CELL INVASION; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE; GENE ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; ONCOGENE C MYC; PRIORITY JOURNAL; PROGRAMMED CELL DEATH 4 GENE; PROMOTER REGION; PROTEIN EXPRESSION; TCF4 GENE; TUMOR CELL; TUMOR SUPPRESSOR GENE; UPREGULATION;

APOPTOSIS REGULATORY PROTEINS; BETA CATENIN; BINDING SITES; DOWN-REGULATION; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; RNA-BINDING PROTEINS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84864751547     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.07.004     Document Type: Article

References (41)

1. Shibahara K., Asano M., Ishida Y., Aoki T., Koike T., Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 1995, 166:297-301.
2. Afonja O., Juste D., Das S., Matsuhashi S., Samuels H.H. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 2004, 23:8135-8145.
3. Zhang H., Ozaki I., Mizuta T., Hamajima H., Yasutake T., Eguchi Y., Ideguchi H., Yamamoto K., Matsuhashi S. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 2006, 25:6101-6112.
4. Guo X., Li W., Wang Q., Yang H.S. AKT activation by Pdcd4 knockdown up-regulates cyclin D1 expression and promotes cell proliferation. Genes Cancer 2011, 2:818-828.
5. Wei N., Liu S.S., Chan K.K., Ngan H.Y. Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer. PLoS One 2012, 7:e30311.
6. Wei Z.T., Zhang X., Wang X.Y., Gao F., Zhou C.J., Zhu F.L., Wang Q., Gao Q., Ma C.H., Sun W.S., Fu Q.Z., Chen Y.H., Zhang L.N. PDCD4 inhibits the malignant phenotype of ovarian cancer cells. Cancer Sci. 2009, 100:1408-1413.
7. Nakashima M., Hamajima H., Xia J., Iwane S., Kwaguchi Y., Eguchi Y., Mizuta T., Fujimoto K., Ozaki I., Matsuhashi S. Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms. Biochim. Biophys. Acta 2010, 1803:1020-1027.
8. Bitomsky N., Bohm M., Klempnauer K.H. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 2004, 23:7484-7493.
9. Singh P., Marikkannu R., Bitomsky N., Klempnauer K.H. Disruption of the Pdcd4 tumor suppressor gene in chicken DT40 cells reveals its role in the DNA-damage response. Oncogene 2009, 28:3758-3764.
10. Eto K., Goto S., Nakashima W., Ura Y., Abe S.I. Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ. 2012, 19:573-581.
11. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., Colburn N.H. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 2001, 20:669-676.
12. Yang H.S., Knies J.L., Stark C., Colburn N.H. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 2003, 22:3712-3720.
13. Jansen A.P., Camalier C.E., Colburn N.H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 2005, 65:6034-6041.
14. Schmid T., Jansen A.P., Baker A.R., Hegamyer G., Hagan J.P., Colburn N.H. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res. 2008, 68:1254-1260.
15. Leupold J.H., Yang H.S., Colburn N.H., Asangani I., Post S., Allgayer H. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 2007, 26:4550-4562.
16. Nieves-Alicea R., Colburn N.H., Simeone A.M., Tari A.M. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Breast Cancer Res. Treat. 2009, 114:203-209.
17. Santhanam A.N., Baker A.R., Hegamyer G., Kirschmann D.A., Colburn N.H. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 2010, 29:3921-3932.
18. Yang H.S., Matthews C.P., Clair T., Wang Q., Baker A.R., Li C.C., Tan T.H., Colburn N.H. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol. Cell. Biol. 2006, 26:1297-1306.
19. Wang Q., Sun Z., Yang H.S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 2008, 27:1527-1535.
20. Wang Q., Sun Z.X., Allgayer H., Yang H.S. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells. Oncogene 2010, 29:128-138.
21. Ma W., Xia C., Ling P., Qiu M., Luo Y., Tan T.H., Liu M. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes. Oncogene 2001, 20:1703-1714.
22. Zhou G., Lee S.C., Yao Z., Tan T.H. Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade. J. Biol. Chem. 1999, 274:13133-13138.
23. Kiefer F., Tibbles L.A., Anafi M., Janssen A., Zanke B.W., Lassam N., Pawson T., Woodgett J.R., Iscove N.N. HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J. 1996, 15:7013-7025.
24. Pelengaris S., Khan M., Evan G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2002, 2:764-776.
25. Wolfer A., Ramaswamy S. MYC and metastasis. Cancer Res. 2011, 71:2034-2037.
26. Wasylishen A.R., Penn L.Z. Myc: the beauty and the beast. Genes Cancer 2010, 1:532-541.
27. Knoepfler P.S. Myc goes global: new tricks for an old oncogene. Cancer Res. 2007, 67:5061-5063.
28. Portereiko M.F., Lloyd A., Steffen J.G., Punwani J.A., Otsuga D., Drews G.N. AGL80 is required for central cell and endosperm development in Arabidopsis. Plant Cell 2006, 18:1862-1872.
29. Morton S., Davis R.J., McLaren A., Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003, 22:3876-3886.
30. Eferl R., Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 2003, 3:859-868.
31. Graham N.A., Asthagiri A.R. Epidermal growth factor-mediated T-cell factor/lymphoid enhancer factor transcriptional activity is essential but not sufficient for cell cycle progression in nontransformed mammary epithelial cells. J. Biol. Chem. 2004, 279:23517-23524.
32. Smith D.R., Myint T., Goh H.S. Over-expression of the c-myc proto-oncogene in colorectal carcinoma. Br. J. Cancer 1993, 68:407-413.
33. Corzo C., Corominas J.M., Tusquets I., Salido M., Bellet M., Fabregat X., Serrano S., Sole F. The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma. Cancer Genet. Cytogenet. 2006, 165:151-156.
34. Onoda N., Maeda K., Chung Y.S., Yano Y., Matsui-Yuasa I., Otani S., Sowa M. Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach. J. Am. Coll. Surg. 1996, 182:55-59.
35. Cho H.J., Oh Y.J., Kwon J., Kwon J.Y., Kim K.S., Kim H. c-Myc stimulates cell invasion by inhibiting FBX8 function. Mol. Cells 2010, 30:355-362.
36. Zhang W., Hart J., McLeod H.L., Wang H.L. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am. J. Clin. Pathol. 2005, 124:11-19.
37. Dong Z., Crawford H.C., Lavrovsky V., Taub D., Watts R., Matrisian L.M., Colburn N.H. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinog. 1997, 19:204-212.
38. Lamb R.F., Hennigan R.F., Turnbull K., Katsanakis K.D., MacKenzie E.D., Birnie G.D., Ozanne B.W. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol. 1997, 17:963-976.
39. Yuspa S.H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci. 1998, 17:1-7.
40. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
41. Sancho R., Nateri A.S., de Vinuesa A.G., Aguilera C., Nye E., Spencer-Dene B., Behrens A. JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J. 2009, 28:1843-1854.